MAIA

MAIA Biotechnology, Inc. (MAIA)

AMEX: MAIAUSD
1.31 USD
-0.07 (-4.89%)
AT CLOSE (11:59 AM EDT)
1.34
+0.03 (+2.37%)
POST MARKET (AS OF 08:15 PM EDT)
🔴Market: CLOSED
Open?$1.41
High?$1.48
Low?$1.29
Prev. Close?$1.31
Volume?2.5M
Avg. Volume?1.1M
VWAP?$1.38
Rel. Volume?2.25x
Bid / Ask
Bid?$1.32 × 100
Ask?$1.35 × 800
Spread?$0.03
Midpoint?$1.34
Valuation & Ratios
Market Cap?79.5M
Shares Out?60.7M
Float?28.6M
Float %?77.2%
P/E Ratio?N/A
P/B Ratio?33.45
EPS?-$0.37
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.66Adequate
Quick Ratio?1.66Adequate
Cash Ratio?1.48Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
33.45HIGH
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-2.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-942.7%WEAK
ROA?
-230.8%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$70.8M
Related Companies
Loading...
News
Profile
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Employees
13
Market Cap
79.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-07-28
Address
444 WEST LAKE STREET, SUITE 1700
CHICAGO, IL 60606
Phone: 312-416-8592